Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04955379
Other study ID # EYEQUE-005
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 15, 2021
Est. completion date July 31, 2023

Study information

Verified date January 2023
Source EyeQue Corp.
Contact Noam Sapiens, PhD
Phone (510) 953-6433
Email noam.sapiens@eyeque.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is exploratory and examines whether the refraction results obtained from a novel optical device yields results similar to the ophthalmic refraction measurements obtained from an autorefractor in children.


Description:

This study is exploratory and examines whether the refraction results obtained from a novel optical device yields results similar to the ophthalmic refraction measurements obtained from an autorefractor in the age stratum of 6 through 17 years.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date July 31, 2023
Est. primary completion date July 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 17 Years
Eligibility Inclusion Criteria: - Male or Female - Ages =6 y.o. and <18 y.o. - Binocular vision - Parent(s) or Guardian(s) willing and able to give informed consent on behalf of the subject. - Subject able to follow all study procedures and requirements Exclusion Criteria: - Spherical correction > +8 or < -10 - Using anticholinergic medications (including first-generation antihistamines) or other medications known to affect visual acuity within the greater of 3 days or 5 half-lives prior to enrolling in this study. - Using an investigational drug or approved therapy for investigational use within the greater of 3 days or 5 half-lives prior to enrolling in this study. - Has initiated any new medication in the past 2 weeks that, in the best medical judgment of the investigator, would impact their participation in the study or ability to use the EyeQue EQ103 device, - Any self/caregiver-reported mental illness or condition of the subject, including but not limited to claustrophobia, fear of simulators, nyctophobia. - Any self/caregiver-reported neurological diseases of the subject, including but not limited to: epilepsy, nystagmus. - Any self/caregiver-reported glaucoma diagnosis of the subject. - Eye disease, including but not limited to: - Cataracts - Macular degeneration - Eye infection (by self-report or observation) - Keratoconus - Diabetic neuropathy/retinopathy - Cytomegalovirus retinitis - Color blindness (any color deficiency) - Diabetic macular edema - Amblyopia - Chronic or acute uveitis - Strabismus - Astigmatism > 3 diopters - Macular hole - Lack physical dexterity to properly operate the EyeQue device. - Lack the ability to follow instruction. - Lack binocular vision. - Are colorblind. - Had eye surgery within the last 12 months.

Study Design


Intervention

Device:
EQ103
Ophthalmic Refractometer with a measurement and background channel

Locations

Country Name City State
Israel Sheba Medical Center Tel HaShomer

Sponsors (2)

Lead Sponsor Collaborator
EyeQue Corp. Sheba Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Tendency of, or achieving, statistical equivalence of refraction measurements EQ103 (non-cycloplegic) compared with autorefractor (non-cycloplegic) Tendency of, or achieving, statistical equivalence of refraction measurements EQ103 (non-cycloplegic) compared with autorefractor (non-cycloplegic) Day 1
Secondary EyeQue EQ103 (non-cycloplegic) and the autorefractor (cycloplegic) assessed by refractive error measured by each device analyzed by age-strata. EyeQue EQ103 (non-cycloplegic) and the autorefractor (cycloplegic) assessed by refractive error measured by each device analyzed in the following age-strata.
Age Groups
6 to 12 y.o. >12 to <18 y.o.
Day 1 and 14
Secondary EyeQue EQ103 (non-cycloplegic) and the autorefractor (cycloplegic) assessed by refractive error measured by each device analyzed by age-strata. EyeQue EQ103 (non-cycloplegic) and the autorefractor (cycloplegic) assessed by refractive error measured by each device analyzed in the following age-strata.
Age Group
6 to 12 y.o.
Day 1 and 14
Secondary EQ103 without cycloplegia will be compared to EQ103 with cycloplegia by younger age-strata. EQ103 without cycloplegia will be compared to EQ103 with cycloplegia in the following age-strata.
Age Group
6 to 12 y.o.
Day 1 and 14
See also
  Status Clinical Trial Phase
Completed NCT04532099 - Clinical Comparison of Two Daily Wear Frequent Replacement Silicone Hydrogel Soft Contact Lenses N/A
Completed NCT05039112 - Clinical Comparison of 2 Daily Disposable Toric Soft Contact Lenses N/A
Completed NCT03670303 - Trial of an Educational Intervention to Promote Spectacle Use Among Secondary School Children in Islamabad, Pakistan N/A
Completed NCT02255474 - Bifocal Lenses In Nearsighted Kids N/A
Not yet recruiting NCT03222661 - Direct Comparison of SVOne Obtained Refraction to Subjective Manifest Refraction N/A
Completed NCT04055519 - Clinical Performance Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens N/A
Recruiting NCT05049070 - Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction N/A
Completed NCT04527978 - Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 1 N/A
Completed NCT01430247 - Vision Screening for the Detection of Amblyopia N/A
Recruiting NCT06077682 - Cycloplegic Refraction in Pediatric Patients With Esotropia Phase 4
Not yet recruiting NCT04077086 - Correcting Myopia Among Secondary School Children to Increase Academic High School Attendance Rates in Rural Communities N/A
Completed NCT04528017 - Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 2 N/A
Withdrawn NCT04352868 - Customizing Myopia Control With Multifocal Toric Contact Lens N/A
Recruiting NCT04338880 - Academic Performance and Refractive Error
Recruiting NCT04545073 - Outcomes of a Trifocal IOL in Post-refractive Patients
Enrolling by invitation NCT05992675 - Air Optix® Night and Day® Aqua Continuous Wear
Enrolling by invitation NCT05976750 - Air Optix® Night and Day® Aqua Daily Wear
Recruiting NCT04693247 - Handheld Device Compared With a Standard Eye Care Diagnostic Device in Measuring Ophthalmic Refraction N/A
Recruiting NCT06065631 - Seeing to Learn in Sierra Leone N/A
Not yet recruiting NCT05550740 - Repeated Low-Level Red-Light Therapy for Shortening Axial Length N/A